Jyong Biotech (MENS) Income Statement: Revenue & Earnings

Jyong Biotech Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Jyong Biotech Ltd. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.12	0.00	0.00	0.00	0.00
Gross Profit	-0.12	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	0.93	1.07	1.29	1.56	1.52
Selling, General & Administrative	1.13	1.73	1.54	0.85	0.93
Operating Expenses	2.06	2.80	2.83	2.40	2.45
Operating Income	-2.06	-2.80	-2.83	-2.40	-2.45
Other Income/Expense
Interest Income	0.01	0.06	0.01	0.01	0.00
Interest Expense	1.04	0.76	0.77	0.84	0.83
Other Income/Expense	0.07	-0.90	-3.04	-1.79	0.53
Income
Income Before Tax	-3.02	-4.40	-6.63	-4.20	-1.92
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-3.02	-4.40	-6.63	-4.20	-1.92
Net Income - Continuous Operations	-3.02	-4.40	-6.63	-4.20	-1.92
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-1.86	-3.52	-5.74	-3.24	-2.34
EBIT	-1.98	-3.64	-5.87	-2.40	-2.45
Depreciation & Amortization	0.12	0.13	0.12	0.12	0.11
Earnings Per Share
Basic EPS	-	-	-	-	-
Diluted EPS	-	-	-	-	-
Basic Shares Outstanding	76.03	76.03	76.03	76.03	71.57
Diluted Shares Outstanding	76.03	76.03	76.03	76.03	71.57